The new edition of the 2016 World Health Organization (WHO) classification system for
tumors of the hematopoietic and lymphoid tissues was published in September 2017. Under …

A group of international experts, including hematopathologists, oncologists, and geneticists
were recently summoned (September 2021, Chicago, IL, USA) to update the 2016/17 World …

The classic Philadelphia chromosome–negative myeloproliferative neoplasms (MPN)
consist of myelofibrosis, polycythemia vera, and essential thrombocythemia and are a …

Purpose To develop a prognostic system for transplantation-age patients with primary
myelofibrosis (PMF) that integrates clinical, cytogenetic, and mutation data. Patients and …

Abstract Disease Overview Primary myelofibrosis (PMF) is a myeloproliferative neoplasm
(MPN) characterized by stem cell‐derived clonal myeloproliferation that is often but not …

Disease overview Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN)
characterized by stem cell‐derived clonal myeloproliferation that is often but not always …

Among 248 consecutive patients with blast phase myeloproliferative neoplasm (MPN-BP),
DNA collected at the time of blast transformation was available in 75 patients (median age …

The 2013 discovery of calreticulin (CALR) mutations in myeloproliferative neoplasms was
attended by their association with longer survival in primary myelofibrosis (PMF) …

Primary myelofibrosis (PMF) is one of three myeloproliferative neoplasms (MPN) that are
morphologically and molecularly inter-related, the other two being polycythemia vera (PV) …

Prefibrotic myelofibrosis (pre-PMF) is a distinct entity among chronic myeloproliferative
neoplasm diagnosed according to the revised 2016 WHO classification. The clinical picture …